Forte Biosciences Inc. (FBRX)
Forte Biosciences Inc - Forte Biosciences Announces Proposed Public Offering
Forte Biosciences Inc - Forte Biosciences Announces Proposed Public Offering
Forte Biosciences Announces Proposed Public Offering
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for April 2026
BELPOINTE OZ ISSUES CHAIRMAN & CEO LETTER TO UNITHOLDERS
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026
Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference
New Era Energy & Digital Closes Multi-Tranche $290 Million Senior Secured Term Loan Credit Facility with Macquarie Group to Finance Texas Critical Data Center Flagship Project
Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Inventiva annonce ledépôt de son Document d’EnregistrementUniversel 2025 et de son Rapport Annuel 2025(« Form 20-F »)